, démontrées la supériorité du gattilier au placebo, et dans les comparaisons à d'autres spécialités, il en ressort que la plante était au moins équivalente. La tolérance à court terme était bonne mais les effets néfastes éventuels à plus long terme n'ont pas été déterminés. Si l'efficacité thérapeutique du gattilier est incontestable, d'autres études devraient être menées afin de confirmer son, 2001.

, De par les nombreuses interactions que les composants de cette plante ont avec divers récepteurs endogènes tels que les D2 ou les opioïdes mu, il pourrait être bénéfique d'utiliser le gattilier dans d'autres indications faisant intervenir ces liaisons

J. Aganoff and G. Boyle, Aerobic exercise, mood states and menstrual cycle symptoms, J Psychosom Res, vol.38, pp.183-192, 1994.

, American College of Obstetricians and Gynecologists. Premenstrual Syndrome : Cinical Management Guidelines for Obstetrician-Gycecologists, ACOG Pract Bull, vol.15, pp.1-9, 2000.

B. Andersch, Bromocriptine and premenstrual syndrome : a survey of double-blind trials, Obstet Gynecol Surv, vol.38, pp.643-689, 1983.

M. Atmaca, S. Kumru, and E. Tezcan, Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder, Hum Psychopharmacol, vol.18, pp.191-196, 2003.

T. Backstrom, D. Haage, and M. Lofgren, Paradoxial effects of GABA-A modulators may explain sex steroid induced negative mood symptoms on some persons, Neuroscience, vol.191, pp.46-54, 2011.

E. Bas, M. C. Recio, and S. Manez, New insight into the inhibition of the inflmmatory response to experimental delayed-type hypersensivity reactions in mice by scropolioside A, European journal of pharmacology, vol.555, pp.199-210, 2007.

E. R. Bertone-johnson, S. E. Hankinson, and S. R. Johnson, Timing of alcohol use and the incidence of premenstrual syndrome and probable premenstrual dysphoric disorder, J Womens Health, vol.18, pp.1945-53, 2009.

E. R. Bertone-johnson, B. W. Whitcomb, and S. A. Missmer, Early life emotional, physical, and sexual abuse and the development of premenstrual syndrome : a longitudinal study, Journal of women's Health, vol.24, 2014.

C. L. Bethea, N. Z. Lu, C. Gundlah, and J. M. Streicher, Diverse actions of ovarian steroids in the serotonin neural system, Front Neuroendocrinol, vol.23, pp.41-100, 2002.

F. Blake, P. Salkovskis, and D. Gath, Cognitive therapy for premenstrual syndrome : a controlled trial, J Psychosom Res, vol.45, pp.307-325, 1998.

J. Bruneton and . Pharmacognosie, Phytochimie, Plantes médicinales. Editions TEC et DOC, Lavoisier, 4 ème édition, pp.790-792, 2009.

D. J. Budeiri, L. W. Po, A. Dornan, and J. C. , Clinical trials of treatments of premenstrual syndrome : entry criteria ans scales for measuring treatment outcomes, Br J Obstet Gynaecol, vol.101, pp.689-95, 1994.

P. W. Budoff, The use of prostaglandin inhibitors for the premenstrual syndrome, J Reprod Med, vol.28, pp.465-468, 1983.

B. Caan, D. Duncan, and R. Hiatt, Association between alcoholic and caffeinated beverages and premenstrual syndrome, J Reprod Med, vol.38, pp.630-636, 1993.

S. Chen, B. Friesen, J. Webster, and D. , Phytoconstituent from Vitex agnus-castus fruits, Fitoterapia, vol.82, pp.528-533, 2011.

L. N. Chin and S. Nambiar, Management of premenstrual syndrome. Obstetrics, Gynaecology and reproductive medicine, vol.27, pp.1-6, 2016.

. Chocano-bedoya and E. R. Bertone-johnson, Premenstrual syndrome, Women Health, pp.179-191

V. Christoffel, B. Spengler, H. Larry, and W. Wuttke, Prolactin in-hibiting dopaminergic activity of diterpens from Vitex ag-nus-castus in Leow D, Phy-topharmaka V, Forschung und klinische Anwendung, pp.209-214, 1999.

C. J. Chuong, C. B. Coulam, P. C. Kao, E. J. Bergstrahl, and V. L. Go, Neuropeptide levels in the premenstrual syndrome, Fertil Steril, vol.44, pp.760-765, 1985.

D. Carlo, G. Mascolo, N. Izzo, and A. Aet, Life. Science, vol.65, pp.337-353, 1999.

D. Pierro, F. Callegari, A. Speroni, M. Attolica, and M. , Fast dissolving agnus castus fruit extract for the premenstrual syndrome. A controlled clinical trial, Nutrafoods, vol.8, pp.27-31, 2009.

F. Dupont and J. L. Guignard, Botanique : les familles de plantes, p.16, 2015.

J. Endicott, U. Halbreich, and S. Schacht, Premenstrual changes and affective disorders, Psychosom Med, vol.43, pp.519-548, 1981.

J. Endicott, J. Nee, J. Cohen, and U. Halbreich, Premenstrual changes : patterns and correlates of daily ratings, J Affect Disord, pp.10-127, 1986.

J. Endicott, J. Nee, and W. Harrison, Daily Record of Severity of Problems (DRSP) : reliability and validity, Arch Womens Ment Health, vol.9, pp.41-49, 2006.

E. Eriksson, SSRIs probably counteract premenstrual syndrome by inhibiting the serotonin transporters, J Psychopharmacol, vol.29, pp.403-408, 2009.

A. European-medicines, Community herbal monograph on Vitex agnus castus L, 2010.

P. Fournier, Le livre des plantes médicinales et vénéneuses de France : 1500 espèces par le texte et par l'image, d'après l'ensemble de nos connaissances actuelles, P. Lechevalier, vol.2, 1948.

E. W. Freeman, R. J. Derubeis, and K. Rickels, Reliability and validity of a daily diary for premenstrual syndrome, Psychiatry Res, vol.65, pp.97-106, 1996.

G. M. Frye and S. D. Silverman, Is it premenstrual syndrome ? Keys to focused diagnosis, therapies for multiple symptoms, Postgrad Med, vol.107, pp.151-160, 2000.

I. L. Goodale, A. D. Domar, and H. Benson, Alleviation of premenstrual symptoms with the relaxation response, Obstet Gynecol, vol.75, pp.649-55, 1990.

C. R. Gracia, E. W. Freeman, and M. D. Sammel, Allopregnanolone levels before and after selective serotonin reuptake inhibitor treatment of prementrual symptoms, J Clin Pharmacolol, vol.29, pp.403-408, 2009.

K. K. Graaze, J. Nee, and J. Endicott, Premenstrual depression predicts future major depressive disorder, Acta Psychiatr Scand, vol.81, pp.201-205, 1990.

P. Guesnet, A. J. Astorg, P. Pifferi, F. , and L. , Les rôles physiologiques majeurs exercés par les acides gras polyinsaturés (AGPI), Filière, vol.12, pp.333-376, 2005.

D. Habek, J. E. Habek, and A. Barbir, Using acupuncture to treat premenstrual syndrome, Arch Gynecol Obstet, vol.267, pp.23-29, 2002.

M. Halaska, P. Beles, C. Gorkow, and C. Sieder, Treatment of cyclical mastalgia with a solution containing a Vitex agnus castus extract : results of a placebo-controlled double-blind study, The Breast, vol.8, pp.175-218, 1999.

U. Halbreich, J. Endicott, S. Schaeht, and J. Nee, The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form, Acta Psychiatr Scand, vol.65, pp.46-65, 1982.

A. Halliday, B. Bush, and P. Cleary, Alcohol abuse in women seeking gynecologic care, Obstet Gynecol, vol.68, pp.322-328, 1986.

F. Hallard and . Abrégé--phytothérapie, , 1998.

Z. He, R. Chen, and Y. Zhou, Treatment for premenstrual syndrome with Vitex agnus cas-tus: a prospective, randomized, multi-center placebo controlled study in China, Maturitas, vol.63, pp.99-203, 2009.

C. Hirobe, Z. S. Qiao, K. Takeya, and H. Itokawa, Cytotoxic flavonoids from Vitex agnus-castus, Phytochemistry, vol.46, pp.521-554, 1997.

E. Hoberg, J. Orjala, B. Meier, and O. Sticher, Diterpenoids from the fruits of Vitex agnus-castus, Phytochemistry, vol.52, pp.1555-1558, 1999.

E. Hoberg and B. Meier, Sticher 0.: Quantitative high perfor-mance liquid chromatography analysis of diterpenoids in Agni-casti fructus, Planta med, vol.66, pp.352-355, 2000.

E. Hoberg and B. Meier, Sticher 0.: A new analytical HPLC method for the determination of agnuside and p-hydroxy-benzoic acid contents in Agni casti fructus, Phytochemical Analysis, 2000.

Y. Hu, T. T. Hou, Q. Y. Zhang, H. L. Xin, H. C. Zheng et al., Evaluation of the estrogenic activity of the constituents in the fruits of Vitex rotundifolia L. for the potential treatment of premenstrual syndrome, J. Pharmacol, vol.59, pp.1307-1312, 2007.

V. Jaishree and S. Badami, Antioxydant and hepatoprotective effect of swertiamarin from from Enicostemma axillare against D-galactosamine induced acute liver damage in rats, J Ethnopharmacol, vol.130, pp.103-106, 2010.

H. Jarry, B. Spengler, A. Porzel, J. Schmidt, W. Wuttke et al., Evidence for estrogen receptor beta-selective activity of Vitex agnus-castus and isolated flavones, Planta Med, vol.69, pp.945-947, 2003.

H. Jarry, S. Leonhardt, C. Gorkow, and W. Wuttke, In vitro prolactin but no LH and FSH release is inhibited by compounds in extracts of Agnus-castus: direct evidence for a dopaminergic principle by the dopamine receptor assay, Exp. Clin. Endocrinol, vol.102, pp.448-454, 1994.

S. R. Johnson, Premenstrual syndrome therapy, Clin Obstet Gynecol, vol.41, pp.405-426, 1998.

R. Kellner, M. T. Buckman, G. A. Fava, and D. Pathak, Hyperprolactinemia, distress and hostility, American journal of prychiatry, vol.141, pp.759-763, 1984.

E. B. Kilicdag, E. Tarim, T. Bagis, and S. Erkanli, Fructus agni casti and bromocriptine for treatment of hyperprolactinemia and mastalgia, Int J Gynecol Obstet, vol.85, pp.292-293, 2004.

A. Kuruuzum-uz, K. Stroch, L. O. Demirezer, and A. Zeeck, Glucosides from Vitex agnus castus, Phytochemistry, vol.63, pp.959-964, 2003.

C. H. Lauritzen, H. D. Reuter, R. Repges, K. J. Böhnert, and U. Schmidt, Treatment of pre-menstrual tension syndrome with Vitex agnus castus. Controlled, double-blind study versus pyridoxine, Phytomedicine, vol.4, pp.183-189, 1997.

S. Li, H. Zhang, S. Qiu, X. Niu, B. D. Santarsiero et al., Vitexlactam A, a novel labdane diterpene lactam from the fruits of Vitex agnuscastus, Tetrahedron Lett, vol.43, pp.5131-5134, 2002.

J. H. Liu, J. E. Burdette, H. Y. Xu, C. G. Gu, R. B. Van-breemen et al., Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms, J Agric Food Chem, vol.49, pp.2472-2479, 2001.

R. S. London, L. Murphy, K. E. Kitlowski, and M. A. Reynolds, Efficacy of alpha-tocopherol in the tratment of the premenstrual syndrome, Recent Adv Clin Nutr, vol.32, pp.400-404, 1987.

T. Lovick, SSRIs and the female brain potential for utilizing steroid-stimulating properties to treat menstrual cycle-linked dysphorias, J Psychopharmacol, vol.27, p.1185, 2013.

, Low Dog T. Premenstrual syndrome. Integrative approach to disease, vol.56, pp.560-568, 2001.

M. K. Lustyk, W. G. Gerrich, S. Shaver, and S. L. Keys, Cognitive-behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder : a systematic review, Arch. Womens Mental Health, vol.12, pp.85-96, 2009.

A. Milewicz, E. Geideil, and H. Sworen, Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double blind study, Arnzneimittel Forsch, vol.43, pp.752-756, 1993.

L. Ma, S. Lin, R. Chen, Y. Zhang, F. Chen et al., Evaluating therapeutic effect in symptoms of moderate-to-severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women, Aust N Z J Obstet Gynaecol, vol.50, pp.189-193, 2010.

J. Marjoribanks, J. Brown, P. M. O'brien, and K. Wyatt, Selective serotonin reuptake inhibitors for premenstrual syndrome, Cochrane Database Systematic Review, vol.7, 1396.

P. E. Martinez, D. R. Rubinow, and L. K. Nieman, 5alpha-reductase inhibition prevents the luteal phase increase in plasma allopregnanolone levels and mitigates symptoms in women with premenstrual dysphoric disorder, Neuropsychopharmacology, vol.41, pp.1093-102, 2016.

M. R. Munday, M. G. Brush, and R. W. Taylor, Correlations between progesterone, oestradiol, and aldosterone levels in the premenstrual syndrome, Clin Endocrinol, vol.14, pp.1-9, 1981.

B. Meier, D. Berger, E. Hoberg, O. Sticher, and W. Schaffner, Pharmacological activities of Vitex agnus-castus extracts in vitro, Phytomedicine, vol.7, pp.373-381, 2000.

M. L. Moline and S. M. Zendell, Evaluating and managing premenstrual syndrome, Medscape Women's Health, vol.2, p.3, 1997.

R. H. Moos, Typology of menstrual cycle symptoms, Am J Obstet Gyneco, vol.103, pp.390-402, 1969.

J. F. Mortola, From GnRH to SSRIs and beyond :weighing the options for drug therapy in premenstrual syndrome, Medscape Women's Health, vol.2, p.3, 1997.

J. F. Mortola, L. Girton, L. Beck, and Y. Ssc, Diagnosos of premenstrual syndrome by a simple, prospective, and reliable instrument : The Calendar of premenstrual experiences, Obstet Gynecol Clin North Am, vol.76, pp.302-309, 1990.

T. B. Pearlstein and A. B. Stone, Premenstrual syndrome, Psychiatr Clin Norh Am, vol.21, pp.577-90, 1998.

T. B. Pearlstein, G. A. Bachmann, H. A. Zacur, and K. A. Yonkers, Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation, Contraception, vol.72, pp.414-435, 2005.

T. Pearstein and M. Steiner, Non-antidepressant treatment of premenstrual syndrome, J Clin Psychiatr, vol.61, issue.12, pp.22-29, 2000.

J. G. Penland and P. E. Johnson, Dietary calcium and manganese effects on menstrual cycle symptoms, Am J Obstet Gynecol, vol.168, pp.1417-1440, 1993.

C. E. Pilver, S. Kasl, R. Desai, and B. R. Levy, Health advantage for black women: patterns in premenstrual dysphoric disorder, Psychol Med, vol.41, pp.1741-50, 2011.

J. C. Prior, Y. Vigna, and D. Sciarretta, Conditioning exercise decreases prementrual symptoms : a prospective, controlled 6-month trial, Fertil Steril, vol.57, pp.402-410, 1987.

A. M. Rossignol and H. Bonnlander, Prevalence and severity of premenstrual syndrome. Effects of foods and beverages that are sweet or high in sugar content, J Reprod Med, vol.36, pp.131-137, 1991.

R. Sayegh, I. Schiff, and J. Wurtman, The effect of a carbohydrate-rich beverage on mood, appetite and cognitive function in women with premenstrual syndrome, Obstet Gynaecol India, vol.86, pp.520-528, 1995.

R. Schellenberg, Treatment for the premen-strual syndrome with agnus castus fruit extract: prospective, randomized, placebo controlled study, BMJ, vol.322, pp.134-141, 2001.

R. Schellenberg, C. Zimmermann, J. Drewe, G. Hoexter, and C. Zahner, Dose-dependent efficacy of the Vitex agnus castus extract ZE 440 in patients suffering from premenstrual syndrome, Phytomedicine, vol.19, pp.1325-1356, 2012.

P. J. Schmidt, P. E. Martinez, and L. K. Nieman, Premenstrual dysphoric disorder symptoms following ovarian steroid suppression : triggered by change in ovarian steroid levels but not continuous stable levels, American Journal Psychiatry, vol.174, pp.980-989, 2017.

M. L. Sharma, C. S. Rao, and P. L. Duda, Immunostimulatory activity of Picrorhiza kurroa leaf extract, Ethnopharmacol, vol.41, pp.185-192, 1994.

G. Sliutz, P. Speiser, A. M. Schultz, J. Spona, and R. Zeillinger, Agnus castus extracts inhibit prolactin secretion of rat pituitary cells, Hormone and Metabolic Research, vol.25, pp.253-255, 1993.

M. Steiner, R. F. Haskett, and B. J. Caroll, Premenstrual tension syndrome : the development of research diagnostic criteria and new rating scales, Acta Psychiatr Scand, vol.62, pp.177-90, 1980.

T. Jacobs, S. Starkey, P. Bernstein, D. Tian, and J. , Calcium carbonate and the premenstrual syndrome effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group, Am. J. Obstet Gynecol, vol.179, pp.444-452, 1998.

R. Tundis, M. R. Loizzo, and F. Menichini, Biological and pharmacological activities of iridoids : recent developments, vol.8, pp.399-420, 2008.

S. Turner and S. Mills, A double-blind clinical trial on a herbal remedy for premenstrual syndrome: a case study, Complementary Ther Med, vol.1, pp.73-77, 1993.

H. Valnet, Phytothérapie : traitement des maladies des plantes. Maloine, 1975.

A. F. Walkers, D. Souza, M. C. Vickers, and M. F. , Magnesium supplementation alleviates premenstrual symptoms of fluid retention, J Women's Health, vol.7, pp.1157-65, 1998.

D. E. Webster, J. Lu, S. N. Chen, N. R. Farnsworth, and Z. J. Wang, Activation of the mu-opiate receptor by Vitex agnus-castus methanol extracts: Implication for its use in PMS, J Ethnopharmacol, vol.106, pp.216-221, 2006.

E. Wollenweber and K. Mann, Flavonols from fruits of Vitex agnus-castus, Planta Med, vol.48, pp.126-127, 1983.

N. F. Woods, A. Most, and G. D. Longenecker, Major life events, daily stressors, and perimenstrual symptoms, Nurs Res, vol.34, pp.263-270, 1985.

, World Health Organization. International Classification of Disases. 10th Rev, 1996.

W. Wuttke, H. Jarry, V. Christoffel, B. Spengler, and D. Seidlova-wuttke, Chaste tree (Vitex agnuscastus): pharmacology and clinical indications, Phytomedicine, vol.10, pp.348-357, 2003.

K. M. Wyatt, P. W. Dimmock, P. W. Jones, O. Shaughn, and P. M. Brien, Efficacity of vitamin B6 in the treatment of premenstrual syndrome : systematic review, BMJ, vol.18, pp.1375-1381, 1999.

K. M. Wyatt, P. W. Dimmock, and K. Ismail, The effectiveness of GnRH with and without 'addback' therapy in treating premenstrual syndrome : a meta analysis, BJOG, vol.111, pp.585-93, 2004.

K. A. Yonkers, Premenstrual disorders, American Journal of obstetrics and gynecology, vol.218, pp.68-74, 2018.

K. A. Yonkers, U. Halbriech, and E. Freeman, The Sertraline Premenstrual Dysphoric Collaborative Study Group. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment, JAMA, vol.278, pp.983-991, 1997.

K. A. Yonkers, P. M. O'brien, and E. Eriksson, Pre-menstrual syndrome, Lancet, vol.371, pp.1200-1210, 2008.

Z. Hina, H. Ghazala, . Rizwani, and I. Sumaira, Phytopharmacological review en Vitex agnus castus : a potential medicinal plant, vol.8, pp.24-29, 2016.

F. Zaafrane, R. Faleh, W. Melki, M. Sakouhi, and L. Gaha, Journal de Gynécologie Obstétrique et biologie de la reproduction, vol.36, pp.642-652, 2007.

M. Zamani, N. Neghab, and S. Torabian, Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome, Sites internet consultés, vol.50, pp.101-107, 2011.

, Annexe 2 : Composition de l'huile essentielle dans le Vitex agnus castus L

, Composés retrouvés en quantité importante et pratiquement toujours présents : Monoterpènes hydrocarbonés Monoterpènes oxygénés : Sesquiterpènes Alpha-pinène 1,8-cinéol (E)-beta-farnésène

, Sabinène Terpinèn-4-ol Beta-caryophyllène Limonène Acétate d'alpha-terpènyl -terpinène (Z)-beta-farnésène Beta-sélinène Epi-alpha-cadinol

, The Daily Rating Scale ou prémenstrual diary, vol.9